Literature DB >> 1533467

Signal transduction of V1-vascular vasopressin receptors.

M Thibonnier1.   

Abstract

This review covers the recent developments gained in the exploration of V1-vascular vasopressin (AVP) receptors. We examine the different radioligands available for the pharmacological characterization of these receptors. The immediate transmembrane signaling of V1-vascular AVP receptors involves ligand-receptor complex formation, receptor lateral mobility and internalization, coupling to a Gq protein, activation of phospholipases A2, C and D, translocation and activation of protein kinase C, production of inositol 1,4,5-triphosphate and 1,2-diacylglycerol, mobilization of intracellular calcium, alteration of intracellular pH with activation of the Na+/H+ exchanger, calmodulin activation and myosin light chain phosphorylation. The secondary nuclear signal mechanisms triggered by activation of V1-vascular AVP receptors includes tyrosine phosphorylation, induction of gene expression and protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533467     DOI: 10.1016/0167-0115(92)90067-5

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  17 in total

1.  Mechanisms of AVP-induced glucagon release in clonal alpha-cells in-R1-G9: involvement of Ca(2+)-dependent and -independent pathways.

Authors:  S Yibchok-Anun; H Cheng; T H Chen; W H Hsu
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.

Authors:  J Tsukada; A Tahara; Y Tomura; T Kusayama; N Ishii; T Yatsu; W Uchida; N Taniguchi; A Tanaka
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 3.  Genetics of aggression in voles.

Authors:  Kyle L Gobrogge; Zuoxin W Wang
Journal:  Adv Genet       Date:  2011       Impact factor: 1.944

4.  Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.

Authors:  Kyle K Henderson; Kenneth L Byron
Journal:  J Appl Physiol (1985)       Date:  2007-01-04

5.  Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis.

Authors:  J Chen; G Aguilera
Journal:  J Neuroendocrinol       Date:  2010-10       Impact factor: 3.627

6.  Endothelium-dependent and NO-mediated desensitization to vasopressin in rat aorta.

Authors:  E Millette; D Lamontagne
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

7.  Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.

Authors:  Xue Li; Tung O Chan; Valerie Myers; Ibrul Chowdhury; Xue-Qian Zhang; Jianliang Song; Jin Zhang; Jocelyn Andrel; Hajime Funakoshi; Jeffrey Robbins; Walter J Koch; Terry Hyslop; Joseph Y Cheung; Arthur M Feldman
Journal:  Circulation       Date:  2011-07-11       Impact factor: 29.690

8.  Somatostatin-induced paradoxical increase in intracellular Ca2+ concentration and insulin release in the presence of arginine vasopressin in clonal HIT-T15 beta-cells.

Authors:  Henrique Cheng; Sirintorn Yibchok-Anun; Seung-Chun Park; Walter H Hsu
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

9.  Antiapoptotic effects of vasopressin in the neuronal cell line H32 involve protein kinase Calpha and beta.

Authors:  Jun Chen; Ying Liu; Jae-Won Soh; Greti Aguilera
Journal:  J Neurochem       Date:  2009-06-10       Impact factor: 5.372

10.  Clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients.

Authors:  Nameet Jerath; Helena Frndova; Brian W McCrindle; Rebecca Gurofsky; Tilman Humpl
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.